IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.
- DOI
- 10.1136/tobaccocontrol-2021-056819
- Published
- 2021-10-19
- Container
- Tob Control
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/tobaccocontrol-2021-056819,
title = {IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.},
author = {Berg CJ and Romm KF and Bar-Zeev Y and Abroms LC and Klinkhammer K and Wysota CN and Khayat A and Broniatowski DA and Levine H.},
year = {2023},
journal = {Tob Control},
doi = {10.1136/tobaccocontrol-2021-056819},
url = {https://doi.org/10.1136/tobaccocontrol-2021-056819}
}RIS
TY - JOUR TI - IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation. AU - Berg CJ AU - Romm KF AU - Bar-Zeev Y AU - Abroms LC AU - Klinkhammer K AU - Wysota CN AU - Khayat A AU - Broniatowski DA AU - Levine H. PY - 2023 JO - Tob Control DO - 10.1136/tobaccocontrol-2021-056819 UR - https://doi.org/10.1136/tobaccocontrol-2021-056819 ER -
APA
CJ, B., KF, R., Y, B., LC, A., K, K., CN, W., A, K., DA, B., & H., L. (2023). IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.. Tob Control. https://doi.org/10.1136/tobaccocontrol-2021-056819
Source records
- europe-pmc · retrieved 2026-09-27T05:08:49.838Z